Business 4 min read By Arthur Ellington
Healthcare Founder Argues Hard Markets Build Stronger Companies
A founder with two decades in healthcare says the standard advice to chase easy markets is backwards, and that difficult sectors can create the most durable competitive advantages.
Entrepreneurs are routinely advised to chase large, easy markets where demand is obvious and adoption is quick. But a founder with twenty years of experience in healthcare argues that this conventional wisdom is backwards, and that the hardest markets can offer the strongest competitive advantages to companies willing to understand them.
The argument rests on a simple observation about competition. Easy markets attract capital and entrants quickly, which erodes margins and makes differentiation difficult. Hard markets, by contrast, repel casual competitors. Regulatory complexity, long sales cycles, entrenched incumbents and deep technical requirements all act as barriers that keep out founders looking for a quick win. For those who persist, those same barriers become a moat.
Healthcare is a case in point. The sector is notoriously difficult to enter: it is heavily regulated, fragmented across payers, providers and patients, and shaped by clinical evidence requirements that do not apply in consumer software. Yet those difficulties are precisely why healthcare businesses that solve real problems can build durable positions. Once a company has navigated compliance, earned trust with clinicians and integrated into care pathways, displacing it becomes far harder than swapping out a consumer app.
The founder's argument is not that difficulty is inherently virtuous. Rather, it is that founders should choose markets based on whether they are willing to develop the expertise the market demands. A hard market rewards depth of understanding. A company that takes the time to learn how a sector actually works, who the gatekeepers are and where the real pain points sit can design products that generic entrants cannot replicate.
That perspective runs against much of the advice circulating in startup ecosystems, where investors often push founders toward large addressable markets with low friction. The logic is that speed of adoption matters more than defensibility. But the healthcare experience suggests the opposite can be true over a longer horizon. Companies that spend years earning the right to operate in a complex sector often end up with higher retention, stronger pricing power and fewer competitors.
There are risks. Hard markets can consume capital before revenue arrives, and founders can mistake complexity for opportunity. The discipline required is to distinguish between difficulty that creates durable advantage and difficulty that simply reflects a broken market. The former is worth pursuing; the latter can trap a company indefinitely.
For British founders weighing where to build next, the lesson is that market selection is a strategic choice, not just a question of size. Sectors such as health, energy, defence and regulated financial services are difficult for good reasons. Those reasons are also why the companies that master them can hold their ground long after the easy markets have been picked clean.
6
